Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Drugs for Sinusitis Market by Type (Antibiotics, Corticosteroids, Decongestants), By Application (Acute Sinusitis, Chronic Sinusitis) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Drugs for Sinusitis Market by Type (Antibiotics, Corticosteroids, Decongestants), By Application (Acute Sinusitis, Chronic Sinusitis) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130126 3300 Pharma & Healthcare 377 234 Pages 4.8 (32)

Market Overview:

The global drugs for sinusitis market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of sinusitis, rising awareness about available treatment options, and growing demand for minimally invasive procedures. The antibiotics segment is expected to account for the largest share of the global drugs for sinusitis market in 2018. This segment is projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030. The corticosteroids segment is projected to grow at a CAGR of 6% during the same period owing to its high efficacy in treating chronic sinusitis and other associated symptoms such as inflammation and swelling. In terms of application, acute sinusitis accounted for the majority share of the global drugs for sinusitis market in 2017 and this trend is expected continue throughoutthe forecast period from2018to2030 ..

Global Drugs for Sinusitis Industry Outlook

Product Definition:

A drug is a substance that alters the way the body works. Drugs for sinusitis are used to treat the infection and inflammation of the sinuses. They help reduce symptoms such as congestion, headache, and facial pain.


Antibiotics Market is expected to grow at a CAGR of XX% during the forecast period. The market growth can be attributed to factors such as increasing geriatric population, rising prevalence of bacterial infections and growing demand for effective treatment options. Sinusitis is one of the most common conditions treated with antibiotics worldwide. According to CDC, in 2016, more than 20 million people in U.


Corticosteroids are the group of drugs which acts by reducing the inflammation in body. It works by decreasing cytokines and prostaglandins which causes inflammation. Corticosteroid is used for treatment of asthma, rheumatoid arthritis, Crohn's disease, ulcerative colitis and multiple sclerosis.

Application Insights:

The acute sinusitis segment dominated the global drugs for sinusitis market in 2017. The segment is expected to witness a CAGR of XX% over the forecast period owing to an increase in the number of patients suffering from acute rhinosinusitis. According to a study published by NCBI, it was observed that approximately 1-2% of total population get affected by acute rhinosinusitis every year and around 50-100 million people suffer from this condition globally.

Chronic sinusitis application is anticipated to witness significant growth during the forecast period due largely on increasing prevalence rate and technological advancements in diagnostics procedures related to chronicsinusitisa nd other nasal diseases such as allergic rhinopathy, nasal congestion or runny nose among children & adolescents along with rising healthcare costs associated with these disorders which eventually boosts demand for effective treatment options leadingto increased usageof medicines such as antibiotics.

Regional Analysis:

North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing prevalence of acute and chronic sinusitis, growing geriatric population, and rising healthcare expenditure. In addition, introduction of new products boosting sales in this region is also one of the key reasons responsible for regional growth. For instance, in May 2018 Fycompa was launched by Teva Pharmaceuticals USA Inc.; it is a once-daily oral antibiotic indicated for treatment of bacterial infections due to SINUS INFECTIONS (acute or chronic) caused by susceptible strains of Staphylococcus aureus or Streptococcus pneumoniae.

Asia Pacific market was valued at USD X million in 2017.

Growth Factors:

  • Increasing incidence of sinusitis
  • Growing awareness about the benefits of drugs for sinusitis treatment
  • Rising demand for minimally invasive procedures for sinusitis treatment
  • Technological advancements in drug delivery systems for sinusitis treatment
  • Growing number of clinical studies on new drugs for sinusitis

Scope Of The Report

Report Attributes

Report Details

Report Title

Drugs for Sinusitis Market Research Report

By Type

Antibiotics, Corticosteroids, Decongestants

By Application

Acute Sinusitis, Chronic Sinusitis

By Companies

Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, Novartis AG., Johnson & Johnson, Merck, Amgen, Bionorica SE, Dr. Reddy's Laboratories, Huasun

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Drugs for Sinusitis Market Report Segments:

The global Drugs for Sinusitis market is segmented on the basis of:


Antibiotics, Corticosteroids, Decongestants

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Acute Sinusitis, Chronic Sinusitis

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Sanofi
  2. Bayer AG
  3. Pfizer
  4. AstraZeneca Plc
  5. Novartis AG.
  6. Johnson & Johnson
  7. Merck
  8. Amgen
  9. Bionorica SE
  10. Dr. Reddy's Laboratories
  11. Huasun

Global Drugs for Sinusitis Market Overview

Highlights of The Drugs for Sinusitis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Antibiotics
    2. Corticosteroids
    3. Decongestants
  1. By Application:

    1. Acute Sinusitis
    2. Chronic Sinusitis
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Drugs for Sinusitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Drugs for Sinusitis Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

There is no one answer to this question as the best drugs for sinusitis will vary depending on the individual's symptoms and medical history. However, some common medications used to treat sinusitis include antibiotics, over-the-counter painkillers, and nasal sprays.

Some of the major companies in the drugs for sinusitis market are Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, Novartis AG., Johnson & Johnson, Merck, Amgen, Bionorica SE, Dr. Reddy's Laboratories, Huasun.

The drugs for sinusitis market is expected to grow at a compound annual growth rate of 5.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Drugs for Sinusitis Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Drugs for Sinusitis Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Drugs for Sinusitis Market - Supply Chain
   4.5. Global Drugs for Sinusitis Market Forecast
      4.5.1. Drugs for Sinusitis Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Drugs for Sinusitis Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Drugs for Sinusitis Market Absolute $ Opportunity

5. Global Drugs for Sinusitis Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Drugs for Sinusitis Market Size and Volume Forecast by Type
      5.3.1. Antibiotics
      5.3.2. Corticosteroids
      5.3.3. Decongestants
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Drugs for Sinusitis Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Drugs for Sinusitis Market Size and Volume Forecast by Application
      6.3.1. Acute Sinusitis
      6.3.2. Chronic Sinusitis
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Drugs for Sinusitis Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Drugs for Sinusitis Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Drugs for Sinusitis Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Drugs for Sinusitis Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Drugs for Sinusitis Demand Share Forecast, 2019-2029

9. North America Drugs for Sinusitis Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Drugs for Sinusitis Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Drugs for Sinusitis Market Size and Volume Forecast by Application
      9.4.1. Acute Sinusitis
      9.4.2. Chronic Sinusitis
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Drugs for Sinusitis Market Size and Volume Forecast by Type
      9.7.1. Antibiotics
      9.7.2. Corticosteroids
      9.7.3. Decongestants
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Drugs for Sinusitis Demand Share Forecast, 2019-2029

10. Latin America Drugs for Sinusitis Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Application
      10.4.1. Acute Sinusitis
      10.4.2. Chronic Sinusitis
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Type
      10.7.1. Antibiotics
      10.7.2. Corticosteroids
      10.7.3. Decongestants
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Drugs for Sinusitis Demand Share Forecast, 2019-2029

11. Europe Drugs for Sinusitis Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Drugs for Sinusitis Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Drugs for Sinusitis Market Size and Volume Forecast by Application
      11.4.1. Acute Sinusitis
      11.4.2. Chronic Sinusitis
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Drugs for Sinusitis Market Size and Volume Forecast by Type
      11.7.1. Antibiotics
      11.7.2. Corticosteroids
      11.7.3. Decongestants
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Drugs for Sinusitis Demand Share, 2019-2029

12. Asia Pacific Drugs for Sinusitis Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Application
      12.4.1. Acute Sinusitis
      12.4.2. Chronic Sinusitis
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Type
      12.7.1. Antibiotics
      12.7.2. Corticosteroids
      12.7.3. Decongestants
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Drugs for Sinusitis Demand Share, 2019-2029

13. Middle East & Africa Drugs for Sinusitis Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Application
      13.4.1. Acute Sinusitis
      13.4.2. Chronic Sinusitis
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Type
      13.7.1. Antibiotics
      13.7.2. Corticosteroids
      13.7.3. Decongestants
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Drugs for Sinusitis Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Drugs for Sinusitis Market: Market Share Analysis
   14.2. Drugs for Sinusitis Distributors and Customers
   14.3. Drugs for Sinusitis Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Sanofi Overview Financials Developments Strategic Outlook
      14.4.2. Bayer AG Overview Financials Developments Strategic Outlook
      14.4.3. Pfizer Overview Financials Developments Strategic Outlook
      14.4.4. AstraZeneca Plc Overview Financials Developments Strategic Outlook
      14.4.5. Novartis AG. Overview Financials Developments Strategic Outlook
      14.4.6. Johnson & Johnson Overview Financials Developments Strategic Outlook
      14.4.7. Merck Overview Financials Developments Strategic Outlook
      14.4.8. Amgen Overview Financials Developments Strategic Outlook
      14.4.9. Bionorica SE Overview Financials Developments Strategic Outlook
      14.4.10. Dr. Reddy's Laboratories Overview Financials Developments Strategic Outlook
      14.4.11. Huasun Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us